Market Overview

UPDATE: Monness Crespi Hardt Downgrades Monsanto

Share:
Related MON
Blue Apron, Boeing, Chipotle, Monsanto: Fast Money Picks For September 21
What Pharmaceuticals Spend On Lobbying To Influence Trump

Chris Shaw of Monness Crespi Hardt downgraded Monsanto Company (NYSE: MON) on Tuesday to Neutral from Buy with a price target lowered to $127 from a previous $140.

"We are downgrading Monsanto from Buy to Neutral, due to the findings from our seventh Annual Seed Dealer Survey, which came back the most negative for the seed industry in the history of the survey," Shaw wrote. The analyst adds that the more than 50 dealers that responded to the survey are experiencing some of the most challenging conditions for the industry over the past seven years.

Shaw states that dealers reported that they are seeing greater discounting, reduced trait purchases, reduced spending on seeds while competing against non-major seed brands who are gaining share.

The analyst also notes that according to the survey, farmers are cutting spending for seed, fertilizer and precision agriculture this year, despite the "conventional wisdom" that seed would be the last place farmers would cut.

"The unprecedented results of this year's survey has led us to be more cautious on Monsanto's outlook for the current seed selling season," Shaw wrote.

As a result, Shaw lowered his 2015 EPS estimate to $5.80 from a previous $5.90.

Latest Ratings for MON

DateFirmActionFromTo
Aug 2017UBSDowngradesBuyNeutral
Jul 2017JefferiesDowngradesBuyHold
Jun 2017SusquehannaDowngradesPositiveNeutral

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Chris Shaw Farmers fertilizer Monness Crespi HardtAnalyst Color Downgrades Price Target Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!
Loading...
Loading...